Divi’s Labs hits record ₹11,824 on strong Q2 earnings

Divi’s Laboratories hit a record ₹11,824 on 9 November 2026 after Q2 results, with support seen near the ₹11,000 level. Divi’s Laboratories Limited [ DIVISLAB ] hit a fresh all-time high of ₹11,824 by 12:25 pm on 9 November 2026. The stock was up over 6% at the peak. The move follows Q2FY27 results. Revenue rose 35% year on year to ₹3,676 crore, led by Custom Synthesis, up 44% to ₹2,200 crore. EBITDA margin widened 989 basis points to 42.6%. Adjusted profit after tax grew 64% to ₹1,127 crore. Market capitalisation crossed ₹3 trillion for the first time. On the daily chart, the stock has broken out of a long range near ₹6,000 to ₹7,000 and has climbed in steps since. Volume on the latest bar is already near the higher readings of recent months. The trend is strongly bullish. At an all-time high, there is no overhead supply on the chart, so resistance is not defined. Support is at the ₹11,000 psychological level, just below the session low of ₹11,071. A daily close below ₹11,000 would weaken the setup. The stock is up 32% in 12 sessions, so a pause or profit booking would be normal. Watch whether it holds ₹11,000 and closes above ₹11,824 on strong volume. Stance: bullish while above ₹11,000. Disclosure I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.